Lannett Recalls Prednisone Tablets Due to Labeling Error
Lannett Company, Inc. is recalling specific batches of Prednisone Tablets due to a labeling error where 2.5 mg bottles contained 10 mg tablets.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a significant dosage discrepancy (2.5 mg vs 10 mg) which poses a risk of harm, but no injuries or illnesses have been reported in the source text.
Plain-English summary
Lannett Company, Inc. is recalling Prednisone Tablets, USP 2.5 mg, 100 tablets, Rx only. The recall is due to a labeling error where bottles labeled to contain 2.5 mg tablets actually contained 10 mg tablets.
The affected product is identified by Batch Number PE190701e1 with an expiry date of June 2021. The product was distributed nationwide in the United States. The tablets were manufactured by Tianjin Tianyao Pharmaceuticals Co., Ltd in Tianjin, China, and distributed by Lannett Company, Inc. in Philadelphia, PA.
Consumers and healthcare providers should check their inventory for the specific batch number and expiry date listed above. If the product matches the recalled description, it should be returned to the pharmacy or distributor. Patients should consult their healthcare provider regarding any medication they have already taken from the affected batch.
The recalled product
- Product
- Prednisone Tablets, USP 2.5 mg, 100 tablets, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, Manufactured by: Tianjin Tianyao Pharmaceuticals Co., Ltd No. 221 Huanghai Road, Tianjin Economical-Technological Development Area, Tianjin, China 300457 NDC 052
- Manufacturer
- Lannett Company, Inc.
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch Number PE190701e1 with expiry June 2021
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Lannett Company, Inc.
See all →- HighAmphetamine extended-release capsules contain immediate-release pellets after label mix-up
FDA (Drugs) · 2026-07-08
- HighLannett niacin extended-release tablets failed dissolution specifications during stability
FDA (Drugs) · 2026-06-10
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateNiacin extended release tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-29
- HighAmphetamine salt tablets recalled after bottles contained a lower strength tablet
FDA (Drugs) · 2025-09-17
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02